About Medusa 19

Medusa 19 is a global distribution company. Our goal is to help responsibly restore confidence to your workforce, enabling your organisation to ramp up productivity in line with government guidelines and help boost the global economy as it recovers from the impact of COVID-19.

Medusa 19’s objective is to entrench itself within the global medical supply chain, serving governments, businesses and consumers worldwide with a range of tests and solutions that identify a variety of conditions, supporting health, well-being and business continuity throughout the globe.

Medusa 19 is also exploring a number of complementary tests and diagnostic products to distribute, and earlier this year entered an exclusive distribution agreement with Avacta Group plc for direct-to-consumer sales of a saliva-based antigen test. It will utilise its infrastructure to distribute these products worldwide as and when available.